|
US6074A
(en)
|
|
1849-01-30 |
|
Machine fob making suspender-buckles |
|
US4468A
(en)
|
|
1846-04-25 |
|
Improvement in casting spoons |
|
US3003A
(en)
*
|
|
1843-03-17 |
|
Improvement in the method of propelling vessels by means of continuous streams of water |
|
US221A
(en)
|
|
1837-06-03 |
|
Steam-boii |
|
US2832685A
(en)
*
|
1952-05-24 |
1958-04-29 |
Crest Foods Co Inc |
Solubilization of milk proteins
|
|
US3528960A
(en)
*
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
|
US3950517A
(en)
*
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
|
US3869437A
(en)
*
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
|
US4179337A
(en)
*
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4033941A
(en)
*
|
1975-12-17 |
1977-07-05 |
Eli Lilly And Company |
Process for purifying glucagon
|
|
JPS6030650B2
(ja)
*
|
1979-10-26 |
1985-07-17 |
日本油脂株式会社 |
座薬基剤組成物
|
|
US4468221A
(en)
|
1981-04-10 |
1984-08-28 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4839341A
(en)
*
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
US4719655A
(en)
*
|
1986-01-21 |
1988-01-19 |
Dean S Brooks |
Invalid transfer device
|
|
US4849227A
(en)
*
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
|
US5266310A
(en)
*
|
1987-09-17 |
1993-11-30 |
Boehringer Ingelheim International Gmbh |
Stabilization of therapeutically active proteins in pharmaceutical preparations
|
|
DE3837825A1
(de)
|
1988-11-08 |
1990-05-10 |
Hoechst Ag |
Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
HUT56857A
(en)
|
1988-12-23 |
1991-10-28 |
Novo Nordisk As |
Human insulin analogues
|
|
DE3844211A1
(de)
*
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
IL93282A
(en)
|
1989-02-09 |
1995-08-31 |
Lilly Co Eli |
Insulin analogues
|
|
US5514646A
(en)
*
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
KR930001305B1
(ko)
*
|
1989-10-19 |
1993-02-25 |
니뽕 유우시 가부시끼가이샤 |
당 응답형 고분자 복합체(Polymer Complexes of Sugar Response Type)
|
|
US5179189A
(en)
*
|
1990-01-19 |
1993-01-12 |
Nova Pharmaceutical Corporation |
Fatty acid terminated polyanhydrides
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5206219A
(en)
*
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
AU5171293A
(en)
*
|
1992-10-14 |
1994-05-09 |
Regents Of The University Of Colorado, The |
Ion-pairing of drugs for improved efficacy and delivery
|
|
AU685784B2
(en)
*
|
1993-02-23 |
1998-01-29 |
Genentech Inc. |
Excipient stabilization of polypeptides treated with organic solvents
|
|
US5359030A
(en)
*
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
JP2837956B2
(ja)
|
1993-06-21 |
1998-12-16 |
ノボ ノルディスク アクティーゼルスカブ |
Ａｓｐ▲上Ｂ２８▼インスリン結晶
|
|
US5506203C1
(en)
*
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
EP1132404A3
(en)
|
1993-09-17 |
2002-03-27 |
Novo Nordisk A/S |
Acylated insulin
|
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
|
US6011007A
(en)
|
1993-09-17 |
2000-01-04 |
Novo Nordisk A/S |
Acylated insulin
|
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US6500645B1
(en)
*
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
US6251856B1
(en)
*
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
|
US20030104981A1
(en)
*
|
1995-11-03 |
2003-06-05 |
Jelena Mandic |
Human insulin analogues
|
|
ZA9610374B
(en)
|
1995-12-11 |
1997-06-23 |
Elan Med Tech |
Cartridge-based drug delivery device
|
|
US6451970B1
(en)
*
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US5981489A
(en)
*
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
PT821006E
(pt)
*
|
1996-07-26 |
2004-09-30 |
Aventis Pharma Gmbh |
Derivados de insulina com ligacao a zinco aumentada
|
|
US5898067A
(en)
*
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
|
US5957895A
(en)
|
1998-02-20 |
1999-09-28 |
Becton Dickinson And Company |
Low-profile automatic injection device with self-emptying reservoir
|
|
TW570805B
(en)
*
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
|
US6660715B2
(en)
*
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
|
US7425541B2
(en)
*
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
|
WO2000047203A1
(en)
*
|
1999-02-12 |
2000-08-17 |
Mqs, Inc. |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
|
CN1141974C
(zh)
*
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
CN1160122C
(zh)
*
|
2001-04-20 |
2004-08-04 |
清华大学 |
一种制备口服胰岛素油相制剂的方法
|
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
EP1423136A4
(en)
*
|
2001-08-10 |
2007-07-25 |
Epix Pharm Inc |
POLYPEPTIDE CONJUGATES WITH EXTENDED CIRCULAR HALF TIME
|
|
US6770625B2
(en)
*
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
|
AU2002314790A1
(en)
*
|
2001-12-05 |
2003-06-23 |
Dow Global Technologies Inc. |
Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
|
|
UA46669C2
(uk)
*
|
2001-12-29 |
2005-12-15 |
Товариство З Обмеженою Відповідальністю "Мако" |
Спосіб приготування готової лікарської форми інсуліну пролонгованої дії
|
|
EP1485443B1
(en)
|
2002-03-18 |
2007-01-03 |
Bespak Plc |
Seal material for a dispensing apparatus
|
|
AU2003236521A1
(en)
*
|
2002-06-13 |
2003-12-31 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
WO2004026794A2
(en)
*
|
2002-09-17 |
2004-04-01 |
Merck & Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
|
PL1633391T3
(pl)
*
|
2003-06-03 |
2012-03-30 |
Novo Nordisk As |
Stabilizowane farmaceutycznie kompozycje peptydowe
|
|
CA2531988C
(en)
*
|
2003-08-05 |
2016-06-28 |
Novo Nordisk A/S |
Novel insulin derivatives
|
|
DK3300721T4
(da)
*
|
2003-11-20 |
2025-03-03 |
Novo Nordisk As |
Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger
|
|
EP1692168B1
(en)
|
2003-12-03 |
2011-07-20 |
Novo Nordisk A/S |
Single-chain insulin
|
|
US7371381B2
(en)
*
|
2003-12-12 |
2008-05-13 |
Amgen Inc. |
Anti-galanin antibodies and uses thereof
|
|
CA2563533C
(en)
*
|
2004-04-15 |
2013-10-01 |
Shmuel A. Ben-Sasson |
Compositions capable of facilitating penetration across a biological barrier
|
|
CA2567056A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
RU2527893C2
(ru)
*
|
2004-07-19 |
2014-09-10 |
Биокон Лимитед |
Инсулин-олигомерные конъюгаты, их препараты и применения
|
|
JP2008510692A
(ja)
|
2004-08-20 |
2008-04-10 |
ノボ ノルディスク アクティーゼルスカブ |
薬学的に活性なインスリン受容体調節分子
|
|
US20080200383A1
(en)
*
|
2005-04-08 |
2008-08-21 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
|
|
WO2007004948A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Astrazeneca Ab |
Environmental detector
|
|
JP2009512709A
(ja)
*
|
2005-10-20 |
2009-03-26 |
エムディーアールエヌエー，インコーポレイテッド |
速効型インスリンの経鼻投与
|
|
RU2524150C2
(ru)
|
2006-09-22 |
2014-07-27 |
Ново Нордиск А/С |
Аналоги инсулина, устойчивые к протеазам
|
|
CN101677944A
(zh)
*
|
2007-06-01 |
2010-03-24 |
诺沃-诺迪斯克有限公司 |
稳定的非含水药物组合物
|
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
EP2370059A1
(en)
*
|
2008-11-28 |
2011-10-05 |
Novo Nordisk A/S |
Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
|